Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy

Ana Amélia de Carvalho Melo-Cavalcante, Leonardo da Rocha Sousa, Marcus Vinícius Oliveira Barros Alencar, José Victor de Oliveira Santos, Ana Maria oliveira da Mata, Márcia Fernanda Correia Jardim Paz, Ricardo Melo de Carvalho, Nárcia Mariana Fonseca Nunes, Muhammad Torequl Islam, Anderson Nogueira Mendes, Juan Carlos Ramos Gonçalves, Felipe Cavalcanti Carneiro da Silva (+2 others)
2019 Biomedicine and Pharmacotherapy  
Cancer development has been directly related to oxidative stress. During chemotherapy, some cancer patients use dietary antioxidants to avoid nutritional deficiencies due to cancer treatment. Among the antioxidants consumed, there are vitamins, including retinyl palmitate (PR) and ascorbic acid (AA), which have the capacity to reduce free radicals formation, protect cellular structures and maintain the cellular homeostasis. This systematic review evaluated the antioxidant and antitumor
more » ... s of retinol palmitate (a derivative of vitamin A) and/or ascorbic acid (vitamin C) in cancer-related studies. Ninety-seven (97) indexed articles in the databases PubMed and Science Direct, published between 2013 and 2017, including 23 clinical studies (5 for every single compound while 13 in interaction) and 74 non-clinical studies (37 for retinol palmitate, 36 for ascorbic acid and 1 in interaction) were considered. Antioxidant and antitumor effects, with controversies over dosage and route of administration, were observed for the test compounds in their isolated form or associated in clinical studies. Prevention of cancer risks against oxidative damage was seen in lower doses of retinol palmitate and/or vitamin C. However, at high doses, they can generate reactive oxygen species, cytotoxicity and apoptosis in test systems. Non-clinical studies using cell lines have allowed understanding the mechanisms related to antioxidants and antitumor effects of the isolated compounds, however, studies on vitamin interactions, acting as antioxidants and/or antitumor are still rare and controversial. More studies, mainly related to modulation of antineoplastic drugs are needed for understanding the risks and benefits of their use during treatment in order to achieve effectiveness in cancer therapy and patient's quality of life.
doi:10.1016/j.biopha.2018.10.115 fatcat:e6vinxh2gzfs7lobl2mutchifm